Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

Brann, David H., Tsukahara, Tatsuya, Weinreb, Caleb, Lipovsek, Marcela, Van den Berge, Koen, Gong, Boying, Chance, Rebecca, Macaulay, Iain C. +17 more·2020·Science Advances
DOI 10.1126/sciadv.abc5801

Cited by (1,000)

Items 101–200 of 1,000

  1. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update
    Jerry J. Lou, Mehrnaz Movassaghi, Dominique E. Gordy, Madeline G. Olson, Ting Zhang, Maya S. Khurana, Zesheng Chen, Mari A. Perez-Rosendahl, Samasuk Thammachantha, Elyse J. Singer et al. · 2020 · Free Neuropathology
  2. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction
    Minjin Jeong, Karen E. Ocwieja, Dongjun Han, Phillip Ashley Wackym, Yichen Zhang, Alyssa Brown, Cynthia Moncada-Reid, Andrea Vambutas, Theodore J. Kanne, Rachel Crain et al. · 2021 · Communications Medicine
  3. Smell and taste symptom‐based predictive model for COVID‐19 diagnosis
    Lauren T. Roland, Jose G. Gurrola, Patricia Anne Loftus, Steven W. Cheung, Jolie L. Chang · 2020 · International Forum of Allergy & Rhinology
  4. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects
    Stephanie I. Shiers, Pradipta R. Ray, Andi Wangzhou, Ishwarya Sankaranarayanan, Claudio Esteves Tatsui, Laurence D. Rhines, Yan Li, Megan L. Uhelski, Patrick M. Dougherty, Theodore John Price · 2020 · Pain
  5. Loss of smell in patients with COVID-19
    Michaël Eliezer, Anne-Laure Hamel, Emmanuel Houdart, Philippe Herman, Juliette Housset, Clément Jourdaine, Corinne Eloit, Benjamin Vérillaud, Charlotte Hautefort · 2020 · Neurology
  6. Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study
    Paolo Boscolo‐Rizzo, Francesco Guida, Jerry Polesel, Alberto Vito Marcuzzo, Paolo Antonucci, Vincenzo Capriotti, Erica Sacchet, Fiordaliso Cragnolini, Andrea D’Alessandro, Enrico Zanelli et al. · 2021 · European Archives of Oto-Rhino-Laryngology
  7. A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details
    Michele Romoli, Ilijas Jelčić, Raphaël Bernard‐Valnet, D. García Azorín, Luca Mancinelli, Tamar Akhvlediani, Salvatore Monaco, P. Taba, Johann Sellner · 2020 · European Journal of Neurology
  8. “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy
    Bevyn Jarrott, Richard J. Head, Kirsty G. Pringle, Eugenie Ruth Lumbers, Jennifer H. Martin · 2022 · Pharmacology Research & Perspectives
  9. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature
    Sivaporn Gatechompol, Anchalee Avihingsanon, Opass Putcharoen, Kiat Ruxrungtham, Daniel R. Kuritzkes · 2021 · AIDS Research and Therapy
  10. Smell and taste disorders during COVID ‐19 outbreak: Cross‐sectional study on 355 patients
    Valeria Dell’Era, Filippo Farri, Giacomo Garzaro, Miriam Gatto, Paolo Aluffi Valletti, Massimiliano Garzaro · 2020 · Head & Neck
  11. Anosmia is associated with lower in-hospital mortality in COVID-19
    Blanca Talavera, David García‐Azorín, Enrique Martínez‐Pías, Javier Trigo-López, Isabel Hernández‐Pérez, Gonzalo Valle‐Peñacoba, Paula Simón Campo, Mercedes de Lera, Alba Chavarría‐Miranda, Cristina López‐Sanz et al. · 2020 · Journal of the Neurological Sciences
  12. Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
    Tom Wai‐Hin Chung, Siddharth Sridhar, Jinxia Zhang, Kwok‐Hung Chan, Hang‐Long Li, Fergus Kai-Chuen Wong, Ming‐Yen Ng, Raymond King‐Yin Tsang, Andrew Chak-Yiu Lee, Zhimeng Fan et al. · 2020 · Open Forum Infectious Diseases
  13. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
    Jessica K. Fiege, Joshua M. Thiede, Hezkiel A. Nanda, William E. Matchett, Patrick J. Moore, Noe Rico Montanari, Beth Kristine Thielen, Jerry J. Daniel, Emma Stanley, Ryan C. Hunter et al. · 2021 · PLoS Pathogens
  14. COVID‐19 and ischemic stroke
    Dimitrios Sagris, Aikaterini Papanikolaou, Alexandra Kvernland, Eleni Korompoki, Jennifer Ann Frontera, Andrea B. Troxel, Maria Gavriatopoulou, Haralampos J. Milionis, Gregory Y.H. Lip, Patrik Michel et al. · 2021 · European Journal of Neurology
  15. SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19
    Aniello Maiese, Alice Chiara Manetti, Chiara Bosetti, Fabio Del Duca, Raffaele La Russa, Paola Frati, Marco Di Paolo, Emanuela Turillazzi, Vittorio Fineschi · 2021 · Brain Pathology
  16. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
    Raziyeh Najafloo, Jila Majidi, Alimohamad Asghari, Mina Aleemardani, Seyed Kamran Kamrava, Sara Simorgh, Amelia Seifalian, Zohreh Bagher, Alexander Marcus Seifalian · 2021 · ACS Chemical Neuroscience
  17. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
    Ida Henriette Caspersen, Per Minor Magnus, Lill Trogstad · 2022 · European Journal of Epidemiology
  18. COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
    Yamamoto, Vicky, Bolanos, Joe F., Fiallos, John, Strand, Susanne E., Morris, Kevin, Shahrokhinia, Sanam, Cushing, Tim R., Hopp, Lawrence, Tiwari, Ambooj, Hariri, Robert et al. · 2020 · Journal of Alzheimer's Disease
  19. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form
    Anna M. Malkova, Igor Vladimirovich Kudryavtsev, Anna Andreevna Starshinova, Dmitry Anatolievich Kudlay, Yulia S. Zinchenko, Anzhela V. Glushkova, P. K. Yаblonskiy, Yehuda Shoenfeld · 2021 · Pathogens
  20. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
    Yiu-Sing Chung, Ching-Yin Lam, Pak-Hei Tan, Hin Fung Tsang, Sze Chuen Cesar Wong · 2024 · International Journal of Molecular Sciences
  21. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients
    Luigi Angelo Vaira, Claire L Hopkins, Marzia Petrocelli, Jerome Rene Lechien, S. Cutrupi, Giovanni Salzano, Carlos Miguel Chiesa-Estomba, Sven Saussez, Giacomo DE RIU · 2020 · Rhinology Journal
  22. Neurological manifestations and neuro‐invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2
    Kristl E.J. Vonck, Ieme Garrez, Veerle De Herdt, Dimitri Hemelsoet, Guy Laureys, Robrecht Raedt, Paul Boon · 2020 · European Journal of Neurology
  23. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks, Susan M., Rosas-Hernandez, Hector, Alejandro Ramirez-Lee, Manuel, Cuevas, Elvis, Talpos, John C. · 2021 · Brain Behavior and Immunity
  24. Acute and Post-Acute Neurological Complications of COVID-19
    Ali Al-Ramadan, Omar Rabab’h, Jawad Shah, Abeer Gharaibeh · 2021 · Neurology International
  25. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
    Kathrin Ohla, Maria Geraldine Veldhuizen, T. Green, Mackenzie E. Hannum, Alyssa J. Bakke, Shima T. Moein, Arnaud Tognetti, Elbrich M. Postma, Robert Pellegrino, Liang‐Dar Hwang et al. · 2022 · Rhinology Journal
  26. Recent trends in aroma release and perception during food oral processing: A review
    Dandan Pu, Yimeng Shan, Juan Wang, Baoguo Sun, Youqiang Xu, Wangang Zhang, Yuyu Zhang · 2022 · Critical Reviews in Food Science and Nutrition
  27. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients
    Serge Daniel Le Bon, Nathalie Pisarski, Justine Verbeke, Léa Prunier, Gaëtan Cavelier, Marie‐Paule Thill, Alexandra Rodriguez, Didier Dequanter, Jerome Rene Lechien, Olivier Le Bon et al. · 2020 · European Archives of Oto-Rhino-Laryngology
  28. Human Type II Taste Cells Express Angiotensin-Converting Enzyme 2 and Are Infected by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Maı̀re E. Doyle, Ashley Appleton, Qing‐Rong Liu, Qin Yao, Caio Henrique Mazucanti, Josephine Mary Egan · 2021 · American Journal Of Pathology
  29. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives
    Gabriele Vargas, Luiz Henrique Geraldo, Natália Gedeão Salomão, Marciano Viana Paes, Flávia Regina Souza Lima, Flávia Carvalho Alcântara Gomes · 2020 · Brain Behavior & Immunity - Health
  30. Silent hypoxaemia in COVID‐19 patients
    Tatum S. Simonson, Tracy L. Baker, Robert B. Banzett, Tammie Bishop, Jerome A. Dempsey, Jack L. Feldman, Patrice G. Guyenet, Emma J. Hodson, Gordon S. Mitchell, Esteban A. Moya et al. · 2020 · The Journal of Physiology
  31. Inflammation at the crossroads of COVID-19, cognitive deficits and depression
    Natalia M. Lyra e Silva, Fernanda G. Q. Barros‐Aragão, Fernanda G. De Felice, Sergio Teixeira Ferreira · 2022 · Neuropharmacology
  32. Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Yin Yao, Hai Wang, Zheng Liu · 2020 · Clinical & Experimental Allergy
  33. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
    Sonu M. M. Bhaskar, Sian Bradley, Simon Israeli‐Korn, Bindu Menon, Vijay Kumar Chattu, Pravin Thomas, Jasvinder P.S. Chawla, Rajeev Kumar, Paolo Prandi, Daniel Ray et al. · 2020 · Frontiers in Neurology
  34. Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb
    Moritz Klingenstein, Stefanie Klingenstein, Peter H. Neckel, Andreas F. Mack, A. Wagner, Alexander Kleger, Stefan Liebau, Alfio Milazzo · 2020 · Cells Tissues Organs
  35. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
    Valeria Fumagalli, Micol Ravà, Davide Marotta, Pietro Di Lucia, Chiara Laura, Eleonora Sala, Marta Grillo, Elisa B. Bono, Leonardo Giustini, Chiara Perucchini et al. · 2022 · Science Immunology
  36. Taste and Smell Impairment in COVID‐19: An AAO‐HNS Anosmia Reporting Tool‐Based Comparative Study
    İbrahim Sayın, Kadriye Kart Yaşar, Zahide Mine Yazıcı · 2020 · Otolaryngology
  37. COVID-19-induced anosmia associated with olfactory bulb atrophy
    Andrew M. Chiu, Nancy J. Fischbein, Max Wintermark, Greg Zaharchuk, Paul T. Yun, Michael Zeineh · 2020 · Neuroradiology
  38. Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia
    Luigi Angelo Vaira, Claire L Hopkins, Ann Sandison, A Manca, Nikolaos Machouchas, Davide Turilli, Jerome Rene Lechien, Maria Rosaria Barillari, Giovanni Salzano, Andrea Cossu et al. · 2020 · The Journal of Laryngology & Otology
  39. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review
    Sheng-Ta Tsai, Ming‐Kuei Lu, Shao San, Chon‐Haw Tsai · 2020 · Frontiers in Neurology
  40. Update on neurological manifestations of COVID-19
    Hanie Yavarpour‐Bali, Maryam Ghasemi‐Kasman · 2020 · Life Sciences
  41. Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Abbas Jarrahi, Meenakshi Ahluwalia, Hesam Khodadadi, Évila Lopes Salles, Ravindra B Kolhe, David Charles Hess, Fernando Ĺ. Vale, Manish Kumar, Babak Baban, Kumar Vaibhav et al. · 2020 · Journal of Neuroinflammation
  42. Essential oils pharmacological activity: Chemical markers, biogenesis, plant sources, and commercial products
    Hamdoon Abdelhamid Mohammed, Ghassan Mohammad Sulaiman, Riaz A. Khan, Ali Z. Al‐Saffar, Mayyadah H. Mohsin, Salim Albukhaty, Ahmed Ismail · 2024 · Process Biochemistry
  43. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
    Pedro Antunes Pousa, Tamires Sara Campos Mendonça, Eduardo Araujo OLIVEIRA, Ana Cristina Simões e Silva · 2020 · Jornal de Pediatria
  44. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System
    Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Benito D. Minjarez, Ulises Gómez‐Pinedo, Ana Laura Márquez-Aguirre, Juan Carlos Mateos‐Díaz, Jorge Matías‐Guiu, Alejandro Arturo Canales-Aguirre · 2021 · Frontiers in Immunology
  45. Principles of odor coding in vertebrates and artificial chemosensory systems
    Ivan Manzini, Detlev Schild, Corrado Di Natale · 2021 · Physiological Reviews
  46. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
    Steven Trent DeKosky, Patrick Michael Kochanek, Alex B. Valadka, Robert S. B. Clark, Sherry Chou, Alicia K. Au, Christopher M. Horvat, Ruchira Menka Jha, Rebekah Mannix, Stephen R. Wisniewski et al. · 2020 · Journal of Neurotrauma
  47. Neurological Complications of COVID-19: Underlying Mechanisms and Management
    Ghaydaa Ahmed Shehata, Kevin C. Lord, Michaela C. Grudzinski, Mohamed Elsayed, Ramy Abdelnaby, Hatem A. Elshabrawy · 2021 · International Journal of Molecular Sciences
  48. Early neurological manifestations of hospitalized COVID-19 patients
    Veria Vacchiano, Patrizia Riguzzi, Lilia Volpi, Maria Tappatà, Patrizia Avoni, Giovanni Rizzo, Luca Guerra, Stefania Zaccaroni, Pietro Cortelli, Roberto Michelucci et al. · 2020 · Neurological Sciences
  49. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms
    Ana C. Puhl, Ethan J. Fritch, Thomas R. Lane, Longping V. Tse, Boyd L. Yount, Carolina Q. Sacramento, Natalia Fintelman Rodrigues, Tatyana Almeida Tavella, Fábio Trindade Maranhão Costa, Stuart M. Weston et al. · 2021 · ACS Omega
  50. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
    Theoharis Constantin Theoharides, Duraisamy Kempuraj · 2023 · Cells
  51. Case Series of Headache Characteristics in COVID‐19: Headache Can Be an Isolated Symptom
    Tuğçe Toptan, Çile Aktan, Ahmet Başarı, Hayrünnisa Bolay · 2020 · Headache The Journal of Head and Face Pain
  52. The Nutrition-COVID-19 Interplay: a Review
    Janet Antwi, Bernard Appiah, Busayo Oluwakuse, Brenda Ariba Zarhari Abu · 2021 · Current Nutrition Reports
  53. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms
    Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth · 2021 · Journal of Neuroimmunology
  54. Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review
    Graziella Orrù, Ciro Conversano, Eleonora Malloggi, Francesca Francesconi, Rebecca Ciacchini, Angelo Gemignani · 2020 · International Journal of Environmental Research and Public Health
  55. COVID-19—Lessons Learned and Questions Remaining
    Ferric C. Fang, Constance Ann Benson, Carlos del Rı́o, Kathryn M. Edwards, Vance G. Fowler, David N. Fredricks, Ajit P. Limaye, Barbara E. Murray, Susanna Naggie, Peter G. Pappas et al. · 2020 · Clinical Infectious Diseases
  56. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
    Emma S. Winkler, Rita E. Chen, Fahmida Alam, Soner Yildiz, James Brett Case, Melissa B. Uccellini, Michael J. Holtzman, Adolfo García‐Sastre, Michael Schotsaert, Michael Diamond · 2021 · Journal of Virology
  57. Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19
    Josefine Radke, Jenny Meinhardt, Tom Aschman, Robert Lorenz Chua, Vadim M. Farztdinov, Soeren Lukassen, Foo Wei Ten, Ekaterina Friebel, Naveed Ishaque, Jonas Franz et al. · 2024 · Nature Neuroscience
  58. SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review
    Jad Gerges Harb, Hussein A Noureldine, Georges Chedid, Mariam Nour Eldine, Dany Abou Abdallah, Nancy Falco Chedid, Wared Nour‐Eldine · 2020 · Pathogens and Disease
  59. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
    Shobi Veleri · 2021 · Experimental Brain Research
  60. Development of the mammalian main olfactory bulb
    Tufo, Candida, Poopalasundaram, Subathra, Dorrego-Rivas, Ana, Ford, Marc C., Graham, Anthony, Grubb, Matthew S. · 2022 · Development
  61. Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare Professionals
    Jesús Porta-Etessam, Jordi A. Matías‐Guiu, N. González-García, Patricia Gómez Iglesias, E. Santos-Bueso, Pedro Arriola‐Villalobos, David García‐Azorín, Jorge Matías‐Guiu · 2020 · Headache The Journal of Head and Face Pain
  62. SARS-CoV-2 infection in the mouse olfactory system
    Qing Ye, Jia Zhou, Qi He, Rui-Ting Li, Guan Yang, Yao Zhang, Shujia Wu, Qi Chen, Jiahui Shi, Rongrong Zhang et al. · 2021 · Cell Discovery
  63. Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19
    Cheng-Ying Ho, Mohammad Salimian, Julia V Hegert, Jennifer OʼBrien, Sun Gyeong Choi, Heather Marion Ames, Meaghan Morris, John C. Papadimitriou, Joseph Mininni, Peter Niehaus et al. · 2022 · JAMA Neurology
  64. Mucosal plasma cells are required to protect the upper airway and brain from infection
    Sebastian A. Wellford, Annie Park Moseman, Kianna Dao, Katherine Wright, Allison P. Chen, Jona E. Plevin, Tzu-Chieh Liao, Naren U. Mehta, E. Ashley Moseman · 2022 · Immunity
  65. Zinc against COVID-19? Symptom surveillance and deficiency risk groups
    Marcin P. Joachimiak · 2021 · PLoS neglected tropical diseases
  66. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
    Paul P. Cheng, Han Zhu, Ronald M. Witteles, Joseph C. Wu, Thomas Quertermous, Sean M. Wu, June‐Wha Rhee · 2020 · Current Cardiology Reports
  67. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michał Sekrecki, Hanna Nowicka, Natalia Łopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoły et al. · 2022 · Frontiers in Immunology
  68. AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives
    Waldemar Andrzej Turski, Artur Wnorowski, Gabrielle N. Turski, Christopher A. Turski, Lechosław Turski · 2020 · Restorative Neurology and Neuroscience
  69. Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes
    Matteo Briguglio, Alberto R. Bona, Mauro Porta, Bernardo Maria Dell’Osso, Fabrizio Ernesto Pregliasco, Giuseppe Banfi · 2020 · Frontiers in Physiology
  70. COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology
    Nicolas Meunier, Loïc VE Briand, Agnès Jacquin, Laurent Brondel, Luc Pénicaud · 2021 · Frontiers in Physiology
  71. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
    Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas, Charles R. Harrington, Yazmin Montserrat Flores-Martinez, Marcos M. Villegas-Rojas, Alfredo M. León-Aguilar, Paola A. Martínez-Gómez, B. Berenice Campa-Córdoba, Ricardo Apátiga-Pérez, Carolin N. Corniel-Taveras et al. · 2021 · Frontiers in Neurology
  72. Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection
    Philippe Voruz, Gilles Allali, Lamyae Benzakour, Anthony Nuber‐Champier, Marine Thomasson, Isabele Jacot de Alcântara, Jordan E. Pierce, Patrice H. Lalive, Karl‐Olof Lövblad, Olivia Braillard et al. · 2022 · Clinical and Translational Neuroscience
  73. Loss of Olfactory Function—Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders
    Heike Rebholz, Ralf J. Braun, Dennis Ladage, Wolfgang Knoll, Christoph Kleber, Achim Walter Hassel · 2020 · Frontiers in Neurology
  74. A Comparative Olfactory MRI, DTI and fMRI Study of COVID-19 Related Anosmia and Post Viral Olfactory Dysfunction
    Düzgün Yıldırım, Sedat Giray Kandemirli, Deniz Esin Tekcan Şanlı, Özlem Akıncı, Aytuğ Altundağ · 2021 · Academic Radiology
  75. COVID-19 Pathogenesis and Clinical Manifestations
    R Alfonso Hernandez Acosta, Zerelda Esquer Garrigos, Jasmine Riviere Marcelin, Prakhar Vijayvargiya · 2022 · Infectious Disease Clinics of North America
  76. Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study
    Arianna Di Stadio, Michael Joel Brenner, Pietro De Luca, Maria Albanese, Luca D’Ascanio, Massimo Ralli, Dalila Roccamatisi, Cristina Cingolani, Federica Vitelli, Angelo Camaioni et al. · 2022 · Brain Sciences
  77. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
    Jaewon James Lee, Scott Kopetz, Eduardo Vilar, John Paul Shen, Ken Chen, Anirban Maitra · 2020 · Genes
  78. SARS-CoV-2 and the Brain: What Do We Know about the Causality of ‘Cognitive COVID?
    Hashir Ali Awan, Mufaddal Najmuddin Diwan, Alifiya Aamir, Muneeza Ali, Massimo Di Giannantonio, Irfan Ullah, Sheikh Shoib, Domenico De Berardis · 2021 · Journal of Clinical Medicine
  79. SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways
    Abhishek Kumar Verma, Jian Hua Zheng, David Kyle Meyerholz, Stanley M. Perlman · 2022 · JCI Insight
  80. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis
    Christopher S. von Bartheld, Lingchen Wang · 2023 · Cells
  81. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
    Caio Henrique Mazucanti, Josephine Mary Egan · 2020 · Immunity & Ageing
  82. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
    Jingman Hu, Jukka Jolkkonen, Chuansheng Zhao · 2020 · Neuroscience & Biobehavioral Reviews
  83. Exploring the Paradox of COVID‐19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
    Sachchida Nand, Neeraj Kumar Tiwari, Payal Singh, Surya Pratap Singh, Divya Mishra, Mohd Imran, Snigdha Singh, Etrat Hooshmandi, Emanuel Vamanu, Santosh Kumar Singh et al. · 2022 · Oxidative Medicine and Cellular Longevity
  84. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection
    Silvia Torices, Rosalba Cabrera, Michael Stangis, Oandy Naranjo, Nikolai S. Fattakhov, Tímea Téglás, Daniel Adesse, Michal J. Toborek · 2021 · Journal of Neuroinflammation
  85. Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
    幸子 小山, Kenji Kondo, Rumi Ueha, Hideki Kashiwadani, Thomas Heinbockel · 2021 · International Journal of Molecular Sciences
  86. Canine olfactory detection and its relevance to medical detection
    Paula Jendrny, Friederike Twele, Sebastian Meller, Albertus Dominicus Marcellinus Eras Osterhaus, Esther Schalke, Holger Andreas Volk · 2021 · BMC Infectious Diseases
  87. Ambient air pollution and COVID-19 risk: Evidence from 35 observational studies
    Sitian Zang, Jie Luan, Ling Li, Hui-Xin Yu, Qi‐Jun Wu, Qing Chang, Yuhong Zhao · 2021 · Environmental Research
  88. SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
    Pinar Mesci, Janaína Sena de Souza, Laura Martin‐Sancho, Ángela Macia, Aurian Saleh, Xin Yin, Cedric E. Snethlage, Jason W. Adams, Simoni Helena Avansini, Roberto H. Herai et al. · 2022 · PLoS Biology
  89. Pathogenetic profiling of COVID-19 and SARS-like viruses
    Zulkar Nain, Humayan Kabir Rana, Píetro Lió, Sheikh Mohammed Shariful Islam, Matthew A. Summers, Mohammad Ali Moni · 2020 · Briefings in Bioinformatics
  90. ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
    Géraldine Descamps, Laurine Verset, Anne Trelcat, Claire L Hopkins, Jerome Rene Lechien, Fabrice Journé, Sven Saussez · 2020 · Biology
  91. Neurological manifestations in COVID-19: A narrative review
    Asma Rahman, Roshan Niloofa, Ishan De Zoysa, Akila Cooray, Jayani Kariyawasam, Suranjith Luke Seneviratne · 2020 · SAGE Open Medicine
  92. Viral infection and smell loss: The case of COVID‐19
    Isaías Glezer, Alexandre Bruni‐Cardoso, Deborah Schechtman, Bettina Malnic · 2020 · Journal of Neurochemistry
  93. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival
    Claire L Hopkins, Jerome Rene Lechien, Sven Saussez · 2020 · Medical Hypotheses
  94. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
    Elnaz Khani, Sajad Khiali, Samineh Beheshtirouy, Taher Entezari‐Maleki · 2021 · European Journal of Pharmacology
  95. Immunological defense of CNS barriers against infections
    Ampie, Leonel, McGavern, Dorian B. · 2022 · Immunity
  96. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions
    Ying Han, Kai Yuan, Zhe Wang, Weijian Liu, Zheng-An Lu, Lin Liu, Le Shi, Wei Yan, Junliang Yuan, Jiali Li et al. · 2021 · Translational Psychiatry
  97. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms
    Alexander Rau, Nils Schroeter, Ganna Blazhenets, Andrea Dreßing, Lea I. Walter, Elias Kellner, Tobias Bormann, Hansjörg Mast, Dirk Wagner, Horst Urbach et al. · 2022 · Brain
  98. Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019
    Daniel J. Lee, Joel Lockwood, Paul Das, Ri Wang, Eitan Grinspun, John Michael Lee · 2020 · Canadian Journal of Emergency Medicine
  99. Frequency and Clinical Utility of Olfactory Dysfunction in COVID-19: a Systematic Review and Meta-analysis
    Khang Wen Pang, Jeremy Chee, Somasundaram Subramaniam, Chew Lip Ng · 2020 · Current Allergy and Asthma Reports
  100. Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell
    Jerome Rene Lechien, Fabrice Journé, Stéphane Hans, Carlos Miguel Chiesa-Estomba, V. Mustin, Eline Beckers, Luigi Angelo Vaira, Giacomo DE RIU, Claire L Hopkins, Sven Saussez · 2020 · Frontiers in Medicine